Skip to main content

. 1979 Jul;8(1):5–6. doi: 10.1111/j.1365-2125.1979.tb05902.x

Validity of cross-over trials.

PMCID: PMC1429712 PMID: 552297

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Aminu J., Vere D. W. A longitudinal study of the mechanisms of action of debrisoquine and propranolol. Br J Clin Pharmacol. 1978 Jul;6(1):43–50. doi: 10.1111/j.1365-2125.1978.tb01680.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
CROMIE B. W. THE FEET OF CLAY OF THE DOUBLE-BLIND TRIAL. Lancet. 1963 Nov 9;2(7315):994–997. doi: 10.1016/s0140-6736(63)90693-7. [DOI] [PubMed] [Google Scholar]
HOGBEN L., SIM M. The self-controlled and self-recorded clinical trial for low-grade morbidity. Br J Prev Soc Med. 1953 Oct;7(4):163–179. doi: 10.1136/jech.7.4.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979 Jul;8(1):7–20. doi: 10.1111/j.1365-2125.1979.tb05903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES